Hospital visits for irregular heart rhythms rising

May 19, 2014

Hospitalizations and costs for treating irregular heartbeats are escalating—increasing the burden on the U.S. healthcare system, according to new research in the American Heart Association journal Circulation.

Atrial fibrillation (AF) is an that can lead to stroke and other heart-related complications.

Researchers, analyzing data from almost 4 million hospitalizations for atrial fibrillation in 2001-10, found:

  • In-hospital deaths declined, but hospitalizations increased by 23 percent, especially in people over age 65.
  • The number of days people were hospitalized didn't change. But after adjusting for inflation, the average cost of hospitalization rose from $6,410 to $8,439—a 24 percent increase.
  • More women were hospitalized, but the difference between men is narrowing.
  • Hospitals in the south had the highest percentage of AF hospitalizations (38 percent) while those in the west had the lowest (14 percent).
  • High was a coexisting condition about 60 percent of the time.
  • Diabetes and lung disease were each coexisting conditions about 20 percent of the time.
  • Rates of kidney failure as a coexisting condition increased four-fold since 2000 and reached 12.3 percent by 2010.
  • In-hospital death rate was highest among those with heart failure (8.2 percent) or older than 80 (about 2 percent).

"Atrial fibrillation is a disease in itself, but it also serves as a marker for the severity of other illnesses," said Nileshkumar Patel, M.D., lead author and internal medicine physician at Staten Island University Hospital, New York.

The hike in hospitalizations is probably because we're living longer and accompanying risk factors such as , obesity, sleep apnea and diabetes are increasing, he said. Generally, the more secondary conditions people had, the longer their hospital stay and the higher their cost.

Researchers analyzed results from the Nationwide Inpatient Sample, the largest in-patient hospital database in the United States. The Agency for Healthcare Research and Quality collected the information from more than 1,200 hospitals across 45 states. The records yielded a cross-section of 3.96 million hospitalizations where atrial fibrillation was the primary diagnosis at discharge.

At least 2.7 million people were living with AF in the United States in 2010, according to the American Heart Association. Seniors over 65 are the fastest growing age group in the United States, which suggests atrial fibrillation will become a major burden on hospitals.

"We must treat and its better in the outpatient setting to prevent hospitalizations and reduce its staggering impact," said Abhishek Deshmukh, M.D., a study author and a cardiologist at the University of Arkansas for Medical Sciences in Little Rock.

Explore further: Atrial fibrillation hospitalizations, costs soar in United States

Related Stories

Atrial fibrillation hospitalizations, costs soar in United States

November 18, 2013
U.S. hospitalizations and costs of care for atrial fibrillation nearly doubled from 1998 to 2010, according to research presented at the American Heart Association's Scientific Sessions 2013.

Minorities face disparities in treatment and outcomes of atrial fibrillation

April 30, 2014
Atrial fibrillation (AF), a condition where the heartbeat speeds up or becomes irregular, is not usually life-threatening but can lead to complications such as stroke and heart failure. Even though minorities historically ...

High blood pressure increases risk of stroke for atrial fibrillation patients

March 31, 2014
Poor blood pressure control among patients with atrial fibrillation is associated with a 50-percent increased risk of stroke, according to an analysis presented by Duke Medicine researchers.

BUSM: Severe sepsis, new-onset AF associated with increased risk of hospital stroke, death

November 13, 2011
A recent study led by researchers at Boston University School of Medicine (BUSM) shows an increased risk of stroke and mortality among patients diagnosed with severe sepsis and new-onset atrial fibrillation (AF) during hospitalization.

'Smart' pacemaker can help slow heart keep up, avoid damage

November 19, 2013
A new generation pacemaker that paces only when rhythm disturbances occur can reduce the risk of permanent abnormal heart rhythms in people with a slow heart rate, according to late-breaking research presented at the American ...

Impact of AF on stroke risk eliminated with multiple risk factors

September 1, 2013
Patients with five or more risk factors have the same stroke risk as patients with atrial fibrillation, according to research presented at the ESC Congress today by Dr. Christine Benn Christiansen from Denmark. The study ...

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.